JPRN-UMIN000044687招募中未知
Evaluation and prevention of diabetic osteosarcopenia in the elderly by nutritional intervention and physical activity advice: DOS study ( Diabetic OsteoSarcopenia study in the elderly): an open, single-arm, prospective, interventional study. - DOS study
Fujita Health University School of Medicine Department of Endocrinology, Diabetes and Metabolism0 个研究点目标入组 80 人开始时间: 2021年6月28日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 80
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 75years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •(1) Patients with obvious dementia or mental illness. (2) Patients using steroids. (3) Patients with hepatic disorder with a Child-Pugh classification of 7 points or higher, or renal dysfunction with a serum creatinine level of 2 mg / dL or higher. (4) Heart failure with restricted physical activity (NYHA classification II or higher). (5) Patients with significant chronic complications of diabetes (nephrosis, active proliferative retinopathy, severe autonomic neuropathy). (6) Patients with an infectious disease corresponding to SIRS (systemic inflammatory response syndrome) or trauma with an AIS (abbreviated injury scale) score of 4 or higher. (7) Patients who are judged to have incurable cancer. (8) Patients with a cardiac pacemaker or implantable cardioverter-defibrillator, etc. (9) Patients with motor paralysis of limbs due to central nervous system disease. (10) Patients who are judged to be inappropriate for this clinical study by the person in charge of research or the research coordinator.
研究者
相似试验
已完成
不适用
Clinical research on the risk factors of Sarcopenia in diabetic patientsDiabetes, Sarcopenia, DynapeniaJPRN-UMIN000020901Tokushima University1,328
已完成
不适用
Sarcopenia and Diabetes MellitusSarcopeniaNCT04407819Dionyssiotis, Yannis, M.D.50
Unknown
4 期
A One-year Randomized Controlled Trial Evaluating the Impact of Pioglitazone Versus Linagliptin on Bone Turnover MarkersDiabetes MellitusOsteoporosisNCT02429232National Taiwan University Hospital160
进行中（未招募）
不适用
Early Prevention of Diabetes Complications in people with Pre-Diabetes in Europeon diabetic hyperglycaemia:Impaired Glucose Tolerance (IGT) or Impaired Fasting Glucose (IFG) or bothMedDRA version: 17.1Level: LLTClassification code 10065542Term: PrediabetesSystem Organ Class: 100000004861EUCTR2013-000418-39-ESFUNDACION DE INVESTIGACION EN RED EN ENFERMEDADES CARDIOVASCULARES (FIRCAVA)3,000
进行中（未招募）
不适用
Early Prevention of Diabetes Complications in people with Pre-Diabetes in Europeon diabetic hyperglycaemia:Impaired Glucose Tolerance (IGT) or Impaired Fasting Glucose (IFG) or bothMedDRA version: 17.1Level: LLTClassification code 10065542Term: PrediabetesSystem Organ Class: 100000004861EUCTR2013-000418-39-ATFUNDACION DE INVESTIGACION EN RED EN ENFERMEDADES3,000